POVIDONES
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 9003398
- UNII
- FZ989GH94E
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Auricular (otic) | Suspension | |
| Buccal | Tablet, Extended Release | 0.5MG |
| Intramuscular | Injection | 0.9% |
| Intravenous | Injectable | 2% |
| Intravenous | Powder, For Injection Solution, Lyophilized | 2% |
| Iv(infusion) | Injection | |
| Ophthalmic | Solution | 2% |
| Ophthalmic | Suspension | 1.8% |
| Ophthalmic | Suspension, Drops | 1.5% |
| Oral | Capsule | 130MG |
| Oral | Capsule (immed./comp. Release), Hard Gelatin | 16MG |
| Oral | Capsule, Coated Pellets | 10.03MG |
| Oral | Capsule, Coated, Soft Gelatin | 6.9MG |
| Oral | Capsule, Delayed Action | 12.38MG |
| Oral | Capsule, Delayed Action, Enteric Coated | |
| Oral | Capsule, Delayed Action, Enteric Coated, Hard Gelatin | 8.7MG |
| Oral | Capsule, Delayed Release | 1.63MG |
| Oral | Capsule, Enteric Coated Pellets | 9.2MG |
| Oral | Capsule, Extended Release | 17.6MG |
| Oral | Capsule, Hard Gelatin | 50MG |
| Oral | Capsule, Soft Gelatin | |
| Oral | Capsule, Sustained Action | 72MG |
| Oral | Drops | |
| Oral | Granule | 100MG |
| Oral | Granule, Effervescent | |
| Oral | Granule, For Oral Suspension | 75MG |
| Oral | Granule, For Suspension | |
| Oral | Granule, For Suspension, Extended Release | |
| Oral | Powder, For Oral Solution | 4.5MG |
| Oral | Powder, For Oral Suspension | 0.12% |
| Oral | Powder, For Reconstitution | |
| Oral | Powder, For Suspension | 0.7% |
| Oral | Solution | 5% |
| Oral | Suspension | 0.4% |
| Oral | Tablet | 160MG |
| Oral | Tablet (immed./comp. Release), Film Coated | 240MG |
| Oral | Tablet (immed./comp. Release), Uncoated, Buccal | 4MG |
| Oral | Tablet (immed./comp. Release), Uncoated, Chewable | 18MG |
| Oral | Tablet, Coated | 49.2MG |
| Oral | Tablet, Controlled Release | 219.03MG |
| Oral | Tablet, Delayed Action | 38MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 35MG |
| Oral | Tablet, Delayed Release | 10.7MG |
| Oral | Tablet, Dispersible | 2MG |
| Oral | Tablet, Extended Release | 101.33MG |
| Oral | Tablet, Film Coated | 116MG |
| Oral | Tablet, Orally Disintegrating | 15.03MG |
| Oral | Tablet, Repeat Action | 10MG |
| Oral | Tablet, Sustained Action | 300MG |
| Oral | Tablet, Sustained Action, Coated | 17MG |
| Oral | Tablet, Sustained Action, Film Coated | 53.33MG |
| Oral | Tablet, Uncoated, Troche | 35MG |
| Oral-20 | Tablet | |
| Oral-21 | Tablet | 14MG |
| Oral-21 | Tablet, Coated | 2.94MG |
| Oral-28 | Tablet | 5.88MG |
| Oral-28 | Tablet, Coated | 2.94MG |
| Subcutaneous | Implant | 6MG |
| Sublingual | Tablet | 8MG |
| Topical | Emulsion, Cream | |
| Topical | Lotion | |
| Topical | Patch | |
| Topical | Solution | 4% |
| Transdermal | Film, Controlled Release | 9.69MG |
| Transdermal | Patch, Controlled Release | 20MG |
| Transdermal | Solution | 2.44% |
| Vaginal | Insert | 49MG |
| Vaginal | Tablet | 50MG |